We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DENTSPLY (XRAY) Q4 Earnings Top Estimates, Sales Up Y/Y
Read MoreHide Full Article
DENTSPLY SIRONA Inc (XRAY - Free Report) is one of the leading worldwide manufacturers’ dental consumables, dental laboratory products, dental specialty products and consumable medical device products. Post DENTSPLY-SIRONA merger, the business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.
Currently, this York, PA- based company carries a Zacks Rank #4 (Sell) but that could change following its fourth quarter 2016 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.) We have highlighted some of the key details from the just-released announcement below: Earnings: DENTSPLY reported adjusted earnings of 67 cents per share, which beat the Zacks Consensus Estimate by 2 cents and was higher than earnings of 65 cents in the year-ago quarter.
Revenues: DENTSPLY’s net sales increased to $996.5 million from $671.1 million in the year-ago period. However this came below the Zacks Consensus Estimate of $1,019.0 million. Sales of the combined businesses grew 4.3% at constant currency (cc) exchange rates.
Key Stats: Dental and Healthcare Consumables sales rose 3.4% year over year at cc, while Technologies grew 5.2% in the quarter.
Major Factors: U.S. business in the fourth quarter was negatively impacted by channel inventory reduction related to a change in distribution strategy in North America. The company expects adjusted EPS for full year 2017 in the range of $2.80 to $2.90 per diluted share.
Stock Price: Shares have risen 6.88% over the past one month, while the Zacks categorized Medical - Dental Supplies sub industry has gained roughly 2.78% over the same time frame.
Check back later for our full write up on this DENTSPLY earnings report later!
Just Released – Driverless Cars: Your Roadmap to Mega-Profits Today
In this latest Special Report, Zacks’ Aggressive Growth Strategist Brian Bolan explores a full-blown technological breakthrough in the making – autonomous cars. He also spotlights 8 stocks with tremendous gain potential to feed off this phenomenon. Click to see the stocks right now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
DENTSPLY (XRAY) Q4 Earnings Top Estimates, Sales Up Y/Y
DENTSPLY SIRONA Inc (XRAY - Free Report) is one of the leading worldwide manufacturers’ dental consumables, dental laboratory products, dental specialty products and consumable medical device products. Post DENTSPLY-SIRONA merger, the business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.
Currently, this York, PA- based company carries a Zacks Rank #4 (Sell) but that could change following its fourth quarter 2016 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.) We have highlighted some of the key details from the just-released announcement below:
Earnings: DENTSPLY reported adjusted earnings of 67 cents per share, which beat the Zacks Consensus Estimate by 2 cents and was higher than earnings of 65 cents in the year-ago quarter.
DENTSPLY SIRONA Inc. Price and EPS Surprise
DENTSPLY SIRONA Inc. Price and EPS Surprise | DENTSPLY SIRONA Inc. Quote
Revenues: DENTSPLY’s net sales increased to $996.5 million from $671.1 million in the year-ago period. However this came below the Zacks Consensus Estimate of $1,019.0 million. Sales of the combined businesses grew 4.3% at constant currency (cc) exchange rates.
Key Stats: Dental and Healthcare Consumables sales rose 3.4% year over year at cc, while Technologies grew 5.2% in the quarter.
Major Factors: U.S. business in the fourth quarter was negatively impacted by channel inventory reduction related to a change in distribution strategy in North America. The company expects adjusted EPS for full year 2017 in the range of $2.80 to $2.90 per diluted share.
Stock Price: Shares have risen 6.88% over the past one month, while the Zacks categorized Medical - Dental Supplies sub industry has gained roughly 2.78% over the same time frame.
Check back later for our full write up on this DENTSPLY earnings report later!
Just Released – Driverless Cars: Your Roadmap to Mega-Profits Today
In this latest Special Report, Zacks’ Aggressive Growth Strategist Brian Bolan explores a full-blown technological breakthrough in the making – autonomous cars. He also spotlights 8 stocks with tremendous gain potential to feed off this phenomenon. Click to see the stocks right now >>